Group 1 - The core index of the China Securities Internet Medical Theme Index (CS Mutual Medical, 930720) rose by 0.25% to 2762.05 points, with a trading volume of 8.387 billion yuan [1] - The CS Mutual Medical Index has increased by 3.77% over the past month, 4.28% over the past three months, and 16.80% year-to-date [1] - The index reflects the overall performance of representative companies providing hardware, software, or services for medical information and intelligence [1] Group 2 - The top ten holdings of the CS Mutual Medical Index include Lepu Medical (6.7%), Jiahe Meikang (5.83%), Haier Biomedical (5.52%), Jiuyuan Yinhai (5.46%), Yaoyigou (5.1%), Weining Health (5.06%), Aier Eye Hospital (5.04%), Sichuang Medical (5.0%), Donghua Software (4.95%), and Daclin (4.92%) [1] - The market share of the CS Mutual Medical Index holdings is 55.77% from the Shenzhen Stock Exchange and 44.23% from the Shanghai Stock Exchange [1] - The industry composition of the index holdings shows that 64.12% is in pharmaceuticals and healthcare, 30.88% in information technology, and 5.00% in communication services [1] Group 3 - The index samples are adjusted quarterly, with adjustments implemented on the next trading day following the second Friday of March, June, September, and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with temporary adjustments made under special circumstances [2] Group 4 - Public funds tracking the CS Mutual Medical Index include Huatai-PineBridge China Securities Internet Medical A and Huatai-PineBridge China Securities Internet Medical C [3]

开出在线医保"首单"，平台型互联网医院再升级 4月27日，上海市杨浦区延吉五村的社区健康大使陈锡峰，将急需的药品送到了同小区75岁独居老 人潘阿婆的手上。 据悉，为在疫情期间全力保障市民的就医购药服务，该平台积极响应上海市号召，与各大公立医院 所建的单体互联网医院医院一道，成为上海首家打通跨院复诊、医保支付、续方购药、送药到家等全流 程服务的平台型互联网医院。在此基础上，上海微医互联网医院创新服务模式，首次落地"社区健康大 使"等社会性志愿服务机制，快速打通了疫情期间居民就医用药的堵点和卡点。 这是上海微医互联网医院打通在线复诊、医保结算后开出的"第一单"，也是平台型互联网医院在上 海开出的医保"首单"。 在该平台多点执业的医生张征表示，互联网医院打破了时间和空间的局限，让有需要的患者能第一 时间问诊开药。"在线医保的开通，将进一步方便患者复诊购药、医保报销，减轻患者在线就医用药的 经济负担。" 作为"上海就医保药应急平台"的服务载体，上海微医互联网医院按照上海市相关部门的要求，在疫 情期间实现跨院复诊、续方配药和医保支付等服务，大大延伸了患者线上复诊的可及性和可获得性。另 外，为保障更多重症慢病患者急需用药 ...

Core Points - The newly released "Internet Diagnosis and Treatment Regulatory Guidelines (Trial)" emphasizes the need for integrated online and offline regulation in internet healthcare, ensuring that online medical services are equivalent to traditional in-person services [1][5][6] - The guidelines are expected to benefit established internet healthcare platforms like WeDoctor, which focus on serious medical services, while promoting the standardization of internet diagnosis and treatment services [1][10] - The regulations aim to raise industry standards and address issues such as the phenomenon of "internet hospitals being built but not used," thereby increasing operational costs and ensuring compliance [7][9] Group 1: Regulatory Framework - The guidelines require that all internet diagnosis and treatment activities must rely on physical medical institutions, ensuring a unified regulatory approach [5][6] - New requirements include that electronic medical records for internet diagnosis must match those of the physical institutions, and healthcare professionals must provide additional information about their practice [5][7] - The guidelines also mandate that provincial health authorities incorporate internet diagnosis into local medical quality control systems [5] Group 2: Industry Impact - The regulations are designed to eliminate unprofessional practices in the industry, such as the use of AI for diagnosis and prescription without a licensed physician's involvement [8][9] - The focus on high-quality medical services will become a core competitive advantage for internet healthcare platforms, moving away from merely selling medications [9][10] - The guidelines are expected to foster a diverse and robust development of internet healthcare, supported by national policies and the integration of digital health systems [10][11] Group 3: Future Prospects - The standardization of regulations is anticipated to facilitate the scale of internet healthcare services, enabling them to gain broader acceptance in insurance reimbursement [11] - The emergence of regional internet hospitals in collaboration with public medical institutions is seen as a model for creating a digital health management system [11] - Overall, the guidelines are expected to create a healthier regulatory environment, leading to greater opportunities and growth in the digital health sector [10][11]

Core Viewpoint - Ping An Good Doctor (01833) saw a stock increase of over 6%, reaching HKD 13.22 with a trading volume of HKD 143 million, following the recognition of its AI medical products by the China Academy of Information and Communications Technology [1] Group 1: Product Recognition and Impact - In July, Ping An Good Doctor's two AI medical products, "Ping An Xinyi" and "An Director," received the "Open Source Large Model + Software Innovation Application Typical Case Honor" from the China Academy of Information and Communications Technology for 2025 [1] - "Ping An Xinyi" leverages a top-tier network of doctors to assist in intelligent patient consultations, medical record organization, rehabilitation suggestions, and post-discharge follow-ups, enhancing the capabilities of doctors [1] - "An Director" completes the family doctor product offering, providing users with 24/7 online and offline integrated services [1] Group 2: Business Strategy and Growth - Zhongtai Securities highlighted the successful outcomes of the company's AI medical products, which enhance operational efficiency and improve user satisfaction [1] - The company is intensifying its efforts in expanding B-end business, introducing new products that combine commercial insurance, health protection delegation, and medical health services to attract corporate clients [1] - The company is strengthening business collaboration with the Ping An Group, utilizing its resources and advantages to promote the development of F-end and B-end businesses, accelerating the implementation of its new strategy [1] - Given the high growth potential of the internet healthcare industry, the company is expected to improve its profitability and optimize its business structure, leading to a "buy" rating from analysts [1]

Core Viewpoint - Ping An Good Doctor (01833) has seen a stock price increase of over 6%, currently at HKD 13.22, with a trading volume of HKD 143 million, following the recognition of its AI medical products by the China Academy of Information and Communications Technology [1] Group 1 - The two AI medical products, "Ping An Xinyi" and "An Director," received the "Open Source Large Model + Software Innovation Application Typical Case Honor" from the China Academy of Information and Communications Technology in July [1] - "Ping An Xinyi" leverages a top-tier network of doctors to assist in intelligent patient consultations, medical record organization, rehabilitation suggestions, and post-discharge follow-ups, enhancing the capabilities of doctors [1] - "An Director" completes the family doctor product offering, providing users with 24/7 integrated online and offline services [1] Group 2 - Zhongtai Securities highlights the successful outcomes of the company's AI medical products, which improve operational efficiency and user satisfaction [1] - The company is intensifying its efforts in expanding B-end business, introducing new products that combine commercial insurance, health protection, and medical health services for corporate clients [1] - The company is strengthening business collaboration with the Ping An Group, utilizing its resources and advantages to promote the development of F-end and B-end businesses, accelerating the implementation of its new strategy [1]

Core Viewpoint - Ping An Good Doctor (01833) saw a stock increase of over 6%, currently trading at 13.22 HKD with a transaction volume of 143 million HKD, driven by the recognition of its AI medical products [1] Group 1: Product Recognition - In July, Ping An Good Doctor's two AI medical products, "Ping An Xin Yi" and "An Zhu Ren," received honors from the China Academy of Information and Communications Technology as typical cases of software innovation applications for the 2025 "Open Source Large Model+" [1] - "Ping An Xin Yi" leverages a top-tier network of doctors to assist in intelligent patient consultations, medical record organization, rehabilitation suggestions, and follow-up care, enhancing the capabilities of doctors [1] - "An Zhu Ren" completes the family doctor product offering, providing users with 24/7 integrated online and offline services [1] Group 2: Business Strategy and Growth - Zhongtai Securities noted that the company's AI medical products have significantly improved operational efficiency and user satisfaction [1] - The company is intensifying its efforts to expand B-end business, introducing new products that combine commercial insurance, health protection, and medical health services for corporate clients [1] - The company is enhancing business collaboration with the Ping An Group, utilizing its resources and advantages to promote the development of F-end and B-end businesses, accelerating the implementation of its new strategy [1] - Given the high growth potential of the internet healthcare industry, the company is expected to improve its profitability and optimize its business structure, leading to a "buy" rating from the securities firm [1]

筑牢技术防线，是治理线上处方药乱象的关键抓手。可建立生物识别体系，在问诊环节强制实施人 脸检测，确保医师与患者身份的真实性。此外，还要建立和完善处方存证平台，将诊断记录、用药方 案、患者反馈等数据上传备查，实现全流程可追溯。针对高风险药品，应设置AI二次审核系统，自动 比对患者历史用药记录与新处方，触发人工复核机制。这方面的技术已成熟，关键在于平台是否愿为公 共安全投入成本。 治本之策则在于纠正错误观念、重塑行业生态。医疗主管部门需建立医师线上诊疗能力认证体系， 将问诊响应时间、病历完整度等指标纳入考核与监督，对长期敷衍了事的线上医生及其所在平台实行淘 汰制。此外，不妨将用药安全和互联网诊疗的特性等内容，纳入公民健康素养教育体系，提升公众对处 方药和线上诊疗特殊性的认知。只有线上医生普遍更加珍视执业声誉，平台更加注重自身责任并强化内 部监管，患者自觉抵制"处方药随便开"等乱象，方能形成全社会共防共治的局面，为这一乱象釜底抽 薪。 互联网医疗还处于早期发展阶段，线上"秒开"处方药乱象也还处于初病时期。有病得早治，若等变 成顽疾再去治理，难度就会更大。也唯有尽早根治这一乱象，方能进一步守护好民众的生命与健康安 全 ...

Core Viewpoint - Internet hospitals are transforming healthcare delivery by leveraging internet technology to provide convenient medical services, building on the resources of traditional hospitals [1] Group 1: Definition and Core Functions - Internet hospitals extend the boundaries of medical services through online platforms, offering functions such as online follow-ups, routine consultations, smart medication advice, and drug delivery [3] - Patients can complete the entire process of follow-up, consultation, medication purchase, payment, and delivery without visiting a hospital, significantly enhancing convenience and efficiency [3] Group 2: Service Characteristics and Advantages - Convenience: Internet hospitals eliminate time and space constraints, allowing patients to access services anytime and anywhere, which is particularly beneficial for chronic disease and mobility-impaired patients [3] - Efficiency: Internet technology enables quick completion of medical processes, reducing long wait times and cumbersome procedures associated with traditional healthcare [3] - Professionalism: Internet hospitals rely on the expertise of medical teams from physical hospitals, ensuring the quality and accuracy of online services through various communication methods [3] - Continuous Management: Internet hospitals focus on long-term health management, allowing doctors to monitor patient conditions and provide personalized treatment plans [3] Group 3: Application Scenarios and Limitations - Internet hospitals are primarily suitable for follow-ups and routine consultations for common and chronic diseases, such as diabetes and hypertension, which require long-term management [4] - They are not equipped to handle first-time consultations or conditions requiring in-person examinations or specialized equipment [4] Group 4: Future Outlook - With ongoing technological advancements and policy support, internet hospitals are expected to expand their applications and development [5] - The integration of artificial intelligence and big data can enhance service intelligence, providing more precise and personalized medical services [5] - Improved telemedicine technology may allow internet hospitals to broaden their service scope, reaching remote areas and grassroots medical institutions, thus promoting equitable distribution of healthcare resources [5]

Group 1 - The company emphasizes the importance of building a core R&D team to maintain technological leadership in the internet healthcare sector [1] - The company focuses on the strategic direction of medical artificial intelligence and continues to invest resources in R&D [1] - The company is adjusting and optimizing compensation and performance evaluation systems to stimulate team potential and ensure technological iteration and product innovation capabilities [1] Group 2 - The company commits to adhering to the essence of healthcare while continuously deepening technological R&D and business innovation [1] - Stakeholders are encouraged to follow the company's regular reports for specific progress updates [1]

Group 1 - The core viewpoint of the news is the performance of the CSI Internet Healthcare Theme Index, which has shown a monthly increase of 6.19%, a three-month increase of 6.77%, and a year-to-date increase of 18.05% [1] - The CSI Internet Healthcare Theme Index is designed to reflect the overall performance of representative companies providing hardware, software, or services for medical informationization and intelligence [1] - The index's top ten holdings include Lepu Medical (6.48%), Jiahe Meikang (6.01%), Jiuyuan Yinhai (5.63%), Yaoyigou (5.31%), Haier Biomedical (5.23%), Weining Health (5.14%), Sichuang Yihui (5.02%), Dashenlin (5.01%), Aier Eye Hospital (4.96%), and Rundar Medical (4.93%) [1] Group 2 - The market share of the CSI Internet Healthcare Theme Index holdings is 55.79% from the Shenzhen Stock Exchange and 44.21% from the Shanghai Stock Exchange [1] - In terms of industry distribution, the holdings are composed of 63.81% in pharmaceuticals and healthcare, 31.17% in information technology, and 5.02% in communication services [1] - The index samples are adjusted quarterly, with adjustments occurring in the second Friday of March, June, September, and December [2]